Search

ASM Health's Phage Therapy Coordination Network (PTCN) brings together stakeholders across the ecosystem to develop practical solutions that improve patient access, accelerate evidence generation and advance the future of phage therapy. Bri

The Bacteriophage special interest group of the Australian ASM, convened by Jeremy Barr, is one of the society's special interest groups. SIGs aim to advance the science of their special interest in microbiology. The Australian Society for

Belgian hub for the world's phage-based solutions, described as a triple helix of academia, industry and government. Its shared mission is to address antimicrobial resistance, sustainable food and crop protection, and animal health. Connect

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufact

The ESCMID Study Group for Non-Traditional Antibacterial Therapy (ESGNTA) brings together professionals to advance the use of bacteriophages and other non-traditional therapies for infectious diseases. Researchers and clinicians working on

The FAGOMA Network of Excellence, created in 2011, brings together 23 research groups from Spanish universities, research centres and technology centres. Members asked the Spanish Society of Virology to create a bacteriophage study group. A

Publisher of PHAGE: Therapy, Applications, and Research. The journal moved from Mary Ann Liebert, Inc. when Sage acquired Liebert (completed December 2024). Mary Ann Liebert, Inc. publishers Acquired by Sage; its journals moved to the Sage

Mikroliz Therapeutic Bacteriophage Bank (MTBB) is established in Turkey which currently has over 800 phages against mainly the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas

Researchers across Ugandan universities collaborating on phages and antimicrobial resistance.

Phages.fr connects researchers, clinicians and industry working on bacteriophages, from basic research to phage therapy, biocontrol and industrial applications. Connecting French research teams across phage biology, therapy, biocontrol and

PhagesDB, the Actinobacteriophage Database, collects and shares data, pictures, protocols and analysis tools on mycobacteriophages, viruses that infect Mycobacteria. It is developed and maintained at the Pittsburgh Bacteriophage Institute,

To promote and conduct phage therapy in Israel and worldwide

Innovate UK's Phage Innovation Network works to address barriers to developing phage-based technologies in the UK. These can serve as diagnostic tools, surveillance tools and sustainable biocontrol agents against antimicrobial resistance. C

A joint Microbial Viruses group sharing research, meetings and opportunities for phage and archaeal virus researchers.

VectorB2B – One-Stop Shop provides highly qualified services of drug discovery and development from the bench to bedside (B2B). VectorB2B gathers the scattered capacities of the Portuguese academic and industrial shareholders in the sector

Viruses of Microbes UK (VoM-UK) is an annual two-day conference hosted by Northumbria University's Microbiome Excellence Peak of Excellence, designed to support postgraduate and early career researchers. An annual meeting community supporti